Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/NAB-Paclitaxel as Therapy for Resectable Pancreatic AdenocarcinomaCIRB: Adult CIRB - Late Phase EmphasisLead Group: SWOGStatus: Temporarily Closed to AccrualReview Status: Available to Open